Rupam Manna/LinkedIn
Jul 19, 2026, 16:59
Rupam Manna: Not All Portal Vein Involvement in HCC Is the Same
Rupam Manna, Postdoctoral Student – DrNB Medical Oncology at National Board of Examinations, shared a post on X:
“Not all portal vein involvement in HCC is the same.
The Vp classification helps define the extent of portal vein tumor thrombosis (PVTT) – one of the most important factors influencing prognosis and treatment strategy in hepatocellular carcinoma.
- Vp0–Vp2: Early vascular involvement where selected patients may still benefit from surgery or locoregional therapies.
- Vp3–Vp4: Major portal vein invasion, usually requiring systemic therapy, with Y-90 radioembolization (TARE) emerging as an important option in carefully selected patients.
Understanding the anatomy of portal vein invasion is key to making the right therapeutic decision.
Save this infographic for a quick review and share it with colleagues interested in liver cancer.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease
-
Sep 3, 2026, 03:51Strengthening Bleeding Disorders Care in New Zealand – WFH
-
Sep 3, 2026, 03:42Nathan Connell: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 3, 2026, 03:28Katrina Snow: Learning More About Sickle Cell Disease This September
-
Sep 3, 2026, 01:19Himanshu Aggarwal: 1 mg/kg/d Thalidomide Non-Inferior to Standard Dose in Transfusion-Dependent Thalassemia
-
Sep 3, 2026, 01:03SHOT Urges Safe Component Matching While NHSBT Appeals for Black Donors
-
Sep 3, 2026, 00:52David Wallace: FDA Approves MIMRYLO to Target Iron Regulation and Reduce Phlebotomy Burden
-
Sep 3, 2026, 00:44Same goal, Different molecular strategy – Which FVIIIa Mimetic Gets There How? – RPTH Journal